Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to
Easing the Disease Burden of Patients with Atopic Dermatitis
Claim This Podcastby Annenberg Center for Health Sciences
5 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to
Language
🇺🇲
Publishing Since
11/1/2021
1 verified contact email on file for Easing the Disease Burden of Patients with Atopic Dermatitis
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
November 1, 2021
Emerging Therapies: Phase 3 Efficacy & Safety Data
<ul> <li>JAK-STAT inhibitors: oral and topical</li> <li>JAK-STAT inhibitors vs dupilumab</li> <li>IL-13 antagonists</li> <li>IL-31 antagonists</li> </ul>
November 1, 2021
AD Therapies Approved After 2014 AAD Guidelines
<ul> <li>Mechanism of action, indication, efficacy, and safety</li> <li>Dupilumab</li> <li>Crisaborole<br> </li> </ul>
November 1, 2021
Adherence to Evidence-Based Guidelines
<ul> <li>2014 AAD Guidelines</li> <li>Recommendations for topical therapies</li> <li>Recommendations for phototherapy</li> </ul>
5 total episodes available
Deep-dive analytics for Easing the Disease Burden of Patients with Atopic Dermatitis
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Easing the Disease Burden of Patients with Atopic Dermatitis?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.